CISATRACURIUM BESYLATE

Generic: CISATRACURIUM BESYLATE

Eugia US LLCManufacturer
INTRAVENOUSRoute
CISATRACURIUM BESYLATEActive Substance
2020-10-27Original Approval

CISATRACURIUM BESYLATE is FDA application ANDA209665, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
ANAESTHETIC COMPLICATION NEUROLOGICAL
110 reports
2
ANAPHYLACTIC SHOCK
60 reports
3
HYPOTENSION
30 reports
4
DRUG INEFFECTIVE
27 reports
5
TOXIC EPIDERMAL NECROLYSIS
24 reports
6
HYPOXIA
23 reports
7
HYPERTHERMIA MALIGNANT
22 reports
8
CYANOSIS
18 reports
9
HYPOKALAEMIA
17 reports
10
TACHYCARDIA
17 reports